Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:ARKG NYSEARCA:ARKK NASDAQ:EXAS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARKGARK Genomic Revolution ETF$24.93+5.6%$24.75$17.51▼$31.16$1.38B1.622.73 million shs4.90 million shsARKKARK Innovation ETF$75.02+0.3%$74.31$38.57▼$79.19$7.26B1.6411.55 million shs6.56 million shsEXASExact Sciences$51.41+4.3%$48.73$38.81▼$72.83$9.73B1.052.80 million shs6.82 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARKGARK Genomic Revolution ETF+0.18%+0.54%+2.88%+11.71%-1.04%ARKKARK Innovation ETF+0.51%-0.97%+1.63%+32.70%+74.01%EXASExact Sciences+2.62%+5.48%+5.21%-9.40%-17.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARKGARK Genomic Revolution ETF$24.93+5.6%$24.75$17.51▼$31.16$1.38B1.622.73 million shs4.90 million shsARKKARK Innovation ETF$75.02+0.3%$74.31$38.57▼$79.19$7.26B1.6411.55 million shs6.56 million shsEXASExact Sciences$51.41+4.3%$48.73$38.81▼$72.83$9.73B1.052.80 million shs6.82 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARKGARK Genomic Revolution ETF+0.18%+0.54%+2.88%+11.71%-1.04%ARKKARK Innovation ETF+0.51%-0.97%+1.63%+32.70%+74.01%EXASExact Sciences+2.62%+5.48%+5.21%-9.40%-17.90%Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AN/AARKKARK Innovation ETFN/AN/AN/AN/AN/AN/AEXASExact Sciences$2.76B3.53$6.11 per share8.42$13.04 per share3.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARKGARK Genomic Revolution ETFN/AN/A0.00∞N/AN/AN/AN/AN/AARKKARK Innovation ETFN/AN/A50.14∞N/AN/AN/AN/AN/AEXASExact Sciences-$1.03B-$5.43N/A102.824.85-34.19%-1.75%-0.76%11/4/2025 (Estimated)Latest EXAS, ARKK, and ARKG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025EXASExact Sciences-$0.02$0.22+$0.24-$0.01$774.43 million$811.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARKGARK Genomic Revolution ETFN/AN/AN/AN/AN/AARKKARK Innovation ETF$0.360.48%N/AN/AN/AEXASExact SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARKGARK Genomic Revolution ETFN/AN/AN/AARKKARK Innovation ETFN/AN/AN/AEXASExact Sciences0.942.892.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARKGARK Genomic Revolution ETFN/AARKKARK Innovation ETFN/AEXASExact Sciences88.82%Insider OwnershipCompanyInsider OwnershipARKGARK Genomic Revolution ETFN/AARKKARK Innovation ETFN/AEXASExact Sciences1.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARKGARK Genomic Revolution ETFN/A44.70 millionN/ANot OptionableARKKARK Innovation ETFN/A96.80 millionN/ANot OptionableEXASExact Sciences7,000189.32 million187.05 millionOptionableEXAS, ARKK, and ARKG HeadlinesRecent News About These CompaniesWhy Exact Sciences (EXAS) Stock Is Trading Up Today1 hour ago | finance.yahoo.comImmuno-Oncology Q2 Earnings: Regeneron (NASDAQ:REGN) Simply the BestSeptember 4 at 5:29 AM | msn.com7,511 Shares in Exact Sciences Corporation $EXAS Bought by Magnetar Financial LLCSeptember 4 at 5:04 AM | marketbeat.comExact Sciences Corporation (EXAS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 3 at 5:01 PM | seekingalpha.comExact Sciences (EXAS) Stock Trades Up, Here Is WhySeptember 3 at 2:14 PM | msn.comLansforsakringar Fondforvaltning AB publ Decreases Stake in Exact Sciences Corporation $EXASSeptember 3 at 5:00 AM | marketbeat.comIeq Capital LLC Buys 18,292 Shares of Exact Sciences Corporation $EXASSeptember 3 at 4:46 AM | marketbeat.comHow Record Q2 Results and a New US$150 Million Savings Plan at Exact Sciences (EXAS) Have Changed Its Investment StorySeptember 2 at 3:38 PM | finance.yahoo.comExact Sciences Corporation $EXAS Stock Holdings Lifted by Armistice Capital LLCSeptember 2 at 8:12 AM | marketbeat.comJefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS)August 31, 2025 | finance.yahoo.comExact Sciences Corporation $EXAS Shares Acquired by Rafferty Asset Management LLCAugust 30, 2025 | marketbeat.comNorthern Trust Corp Decreases Stock Position in Exact Sciences Corporation $EXASAugust 30, 2025 | marketbeat.comChamplain Investment Partners LLC Cuts Stock Position in Exact Sciences Corporation $EXASAugust 29, 2025 | marketbeat.comAlphaQuest LLC Raises Stock Holdings in Exact Sciences Corporation $EXASAugust 29, 2025 | marketbeat.comThematics Asset Management Decreases Holdings in Exact Sciences Corporation $EXASAugust 27, 2025 | marketbeat.comBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Boosts Holdings in Exact Sciences Corporation $EXASAugust 26, 2025 | marketbeat.comExact Sciences Corporation $EXAS Position Cut by Ameriprise Financial Inc.August 26, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Purchases 643,631 Shares of Exact Sciences Corporation $EXASAugust 26, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Has $502,000 Stake in Exact Sciences Corporation $EXASAugust 26, 2025 | marketbeat.comExact Sciences Corporation $EXAS Position Boosted by Hsbc Holdings PLCAugust 26, 2025 | marketbeat.comKorea Investment CORP Has $4.93 Million Stock Holdings in Exact Sciences Corporation $EXASAugust 25, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEXAS, ARKK, and ARKG Company DescriptionsARK Genomic Revolution ETF BATS:ARKG$24.92 +1.32 (+5.57%) Closing price 03:59 PM EasternExtended Trading$24.72 -0.20 (-0.80%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.ARK Innovation ETF NYSEARCA:ARKK$75.02 +0.23 (+0.31%) Closing price 04:10 PM EasternExtended Trading$75.02 0.00 (-0.01%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ARK Innovation ETF (ARKK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that seeks long-term capital growth from companies globally involved with, or that benefit from, disruptive innovation. ARKK was launched on Oct 31, 2014 and is managed by ARK.Exact Sciences NASDAQ:EXAS$51.41 +2.14 (+4.34%) Closing price 04:00 PM EasternExtended Trading$51.20 -0.21 (-0.42%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Insider Selling: Risk Signal or Normal Activity? Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Ambarella's Earnings Prove Its Edge AI Strategy Is a Winner Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
